PhRMA Decries Damaging Foreign Practices in Special 301 Filing
February 08, 2019
February 08, 2019
WASHINGTON, Feb. 8 -- The Pharmaceutical Research and Manufacturers of America issued the following news release:
The Pharmaceutical Research and Manufacturers of America (PhRMA) today urged the Office of the United States Trade Representative (USTR) to take immediate action to address serious and growing market access and intellectual property barriers in top overseas markets.
In its submission for USTR's annual Special 301 Report, PhRMA called on the Trump administrat . . .
The Pharmaceutical Research and Manufacturers of America (PhRMA) today urged the Office of the United States Trade Representative (USTR) to take immediate action to address serious and growing market access and intellectual property barriers in top overseas markets.
In its submission for USTR's annual Special 301 Report, PhRMA called on the Trump administrat . . .